ATC code J05
From Self-sufficiency
| ATC codes |
|---|
| J Antiinfectives for systemic use |
| J01 Antibacterials for systemic use |
| J02 Antimycotics for systemic use |
| J04 Antimycobacterials |
| J05 Antivirals for systemic use |
| Human only |
| J06 Immune sera and immunoglobulins |
| J07 Vaccines |
| ATCvet only |
| QJ51 Antibacterials for intramammary use |
| QJ54 Antimycobacterials for intramammary use |
|
|
ATC code J05 Antivirals for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup J05 is part of the anatomical group J Antiinfectives for systemic use.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QJ05...[2]National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
Contents
- 1 J05A Direct acting antiviral drugs
- 1.1 J05AA Thiosemicarbazones
- 1.2 J05AB Nucleosides and nucleotides excluding reverse transcriptase inhibitors
- 1.3 J05AC Cyclic amines
- 1.4 J05AD Phosphonic acid derivatives
- 1.5 J05AE Protease inhibitors
- 1.6 J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
- 1.7 J05AG Non-nucleoside reverse transcriptase inhibitors
- 1.8 J05AH Neuraminidase inhibitors
- 1.9 J05AR Antivirals for treatment of HIV infections, combinations
- 1.10 J05AX Other antivirals
- 2 References
J05A Direct acting antiviral drugs
J05AA Thiosemicarbazones
- J05AA01 Metisazone
J05AB Nucleosides and nucleotides excluding reverse transcriptase inhibitors
- J05AB01 Aciclovir
- J05AB02 Idoxuridine
- J05AB03 Vidarabine
- J05AB04 Ribavirin
- J05AB06 Ganciclovir
- J05AB09 Famciclovir
- J05AB11 Valaciclovir
- J05AB12 Cidofovir
- J05AB13 Penciclovir
- J05AB14 Valganciclovir
- J05AB15 Brivudine
- J05AB54 Ribavirin, combinations
J05AC Cyclic amines
- J05AC02 Rimantadine
- J05AC03 Tromantadine
J05AD Phosphonic acid derivatives
J05AE Protease inhibitors
- J05AE01 Saquinavir
- J05AE02 Indinavir
- J05AE03 Ritonavir
- J05AE04 Nelfinavir
- J05AE05 Amprenavir
- J05AE06 Lopinavir
- J05AE07 Fosamprenavir
- J05AE08 Atazanavir
- J05AE09 Tipranavir
- J05AE10 Darunavir
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
- J05AF01 Zidovudine
- J05AF02 Didanosine
- J05AF03 Zalcitabine
- J05AF04 Stavudine
- J05AF05 Lamivudine
- J05AF06 Abacavir
- J05AF07 Tenofovir disoproxil
- J05AF08 Adefovir dipivoxil
- J05AF09 Emtricitabine
- J05AF10 Entecavir
- J05AF11 Telbivudine
- J05AF12 Clevudine
J05AG Non-nucleoside reverse transcriptase inhibitors
- J05AG01 Nevirapine
- J05AG02 Delavirdine
- J05AG03 Efavirenz
- J05AG04 Etravirine
J05AH Neuraminidase inhibitors
- J05AH01 Zanamivir
- J05AH02 Oseltamivir
J05AR Antivirals for treatment of HIV infections, combinations
- J05AR01 Zidovudine and lamivudine
- J05AR02 Lamivudine and abacavir
- J05AR03 Tenofovir disoproxil and emtricitabine
- J05AR04 Zidovudine, lamivudine and abacavir
- J05AR05 Zidovudine, lamivudine and nevirapine
- J05AR06 Emtricitabine, tenofovir disoproxil and efavirenz
- J05AR07 Stavudine, lamivudine and nevirapine
J05AX Other antivirals
- J05AX01 Moroxydine
- J05AX02 Lysozyme
- J05AX05 Inosine pranobex
- J05AX06 Pleconaril
- J05AX07 Enfuvirtide
- J05AX08 Raltegravir
- J05AX09 Maraviroc
- J05AX10 Maribavir
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />cs:ATC kód J05 es:Anexo:Código ATC J05 hu:ATC J05 – Szisztémás vírusellenes szerek pl:ATC (J05) ro:Cod ATC J05 ru:АТХ код J05 sv:ATC-kod J05: Virushämmande medel för systemiskt bruk
th:ATC รหัส J05- ↑ "ATC Index". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index". WHO Collaborating Centre for Drug Statistics Methodology.
